Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshikatsu Koga

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Cells|May 9, 2019
Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid TumorsYoshikatsu Koga, Atsushi Ochiai
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 4, 2015
[Fecal Biomarker for Colorectal Cancer Diagnosis]Yoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura
Expert Review of Molecular Diagnostics|December 7, 2013
New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNAYoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Special Issue: Evaluation of the Antitumor Mechanism of Armed AntibodiesYoshikatsu Koga, Hiroki Takashima, Shigehiro Koganemaru
Cancer Science|April 24, 2008
Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumorYohei Saito, Masahiro Yasunaga, Junichiro Kuroda, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2009
Antitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumourYohei Saito, Masahiro Yasunaga, Jun-Ichiro Kuroda, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 16, 2018
Influence of the dissociation rate constant on the intra-tumor distribution of antibody-drug conjugate against tissue factorRyo Tsumura, Shino Manabe, Hiroki Takashima, et al.
Cancer Science|September 25, 2024
Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer modelsRyo Tsumura, Takahiro Anzai, Yoshikatsu Koga, et al.
Cancer Science|July 27, 2019
Evaluation of the antitumor mechanism of antibody-drug conjugates against tissue factor in stroma-rich allograft modelsRyo Tsumura, Shino Manabe, Hiroki Takashima, et al.
Scientific Reports|April 22, 2016
Imaging mass spectrometry for the precise design of antibody-drug conjugatesYuki Fujiwara, Masaru Furuta, Shino Manabe, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Cells|May 9, 2019
Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid TumorsYoshikatsu Koga, Atsushi Ochiai
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 4, 2015
[Fecal Biomarker for Colorectal Cancer Diagnosis]Yoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura
Expert Review of Molecular Diagnostics|December 7, 2013
New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNAYoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Special Issue: Evaluation of the Antitumor Mechanism of Armed AntibodiesYoshikatsu Koga, Hiroki Takashima, Shigehiro Koganemaru
Cancer Science|April 24, 2008
Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumorYohei Saito, Masahiro Yasunaga, Junichiro Kuroda, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2009
Antitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumourYohei Saito, Masahiro Yasunaga, Jun-Ichiro Kuroda, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 16, 2018
Influence of the dissociation rate constant on the intra-tumor distribution of antibody-drug conjugate against tissue factorRyo Tsumura, Shino Manabe, Hiroki Takashima, et al.
Cancer Science|September 25, 2024
Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer modelsRyo Tsumura, Takahiro Anzai, Yoshikatsu Koga, et al.
Cancer Science|July 27, 2019
Evaluation of the antitumor mechanism of antibody-drug conjugates against tissue factor in stroma-rich allograft modelsRyo Tsumura, Shino Manabe, Hiroki Takashima, et al.
Scientific Reports|April 22, 2016
Imaging mass spectrometry for the precise design of antibody-drug conjugatesYuki Fujiwara, Masaru Furuta, Shino Manabe, et al.
Pageof 7